MichelleNBCC
@MichelleTregear
Followers
830
Following
5K
Media
46
Statuses
2K
Advocate and researcher, 2008 breast cancer survivor, Chief Programs Officer for NBCC, and proud supporter of NBCC’s mission. Tweets my own....
Virginia, USA
Joined November 2014
A Fifth of Their Days: The Time Commitments of Advanced Cancer and Its Care | JCO Oncology Practice
ascopubs.org
0
0
0
Applications are closing soon: Bring your advocacy skills to the next level and join NBCC’s Public Policy Academy – a virtual program that convenes monthly to empower the next generation of NBCC advocates. Apply today! https://t.co/GkBKi794F7
0
1
2
Must read: In @WebMD, NBCC's @MichelleTregear wrote about the hidden side effects of breast cancer: Financial toxicity.
webmd.com
The cost of having cancer can ruin your finances. And it’s not just the treatments. An ASCO panel addressed financial toxicity.
0
1
1
How do redlined neighborhoods impact breast cancer survival? The probability of survival was significantly lower depending on inequity in neighborhoods, with some having a 64% higher risk of death within five years of diagnosis. Learn more:
stopbreastcancer.org
During an NBCC webinar, Dr. Sarah Lima explains how historical housing policies continue to have a measurable impact on breast cancer outcomes nearly a century later.
0
1
1
Advances in research are beginning to show that some women may not need as much treatment as traditionally given – and in some cases, may not benefit from it at all. Read @MichelleTregear's analysis of why some patients opt-out of treatment on @WebMD
webmd.com
New research is showing that some people who have breast cancer may not need as much treatment as once thought. Learn more from the ASCO Annual Meeting.
0
1
3
Yup! Important study.
0
0
1
Our founder’s son, Regan along with friends Lydia, Megan and Callum, will be taking on an incredible challenge - climbing 3 peaks in 24 hours on the 12th of July, all to raise vital funds for METUPUK, @thechristiecharity and @mssocietyuk. Every step they take helps fuel awareness
0
4
13
@oncology_bg @Medscape Excellent! Doctors claiming exercise is too expensive, but have no issues with cancer drugs costing 100-150K/year and with serious side effects! 😂
0
4
5
"It’s not just that you are giving people things that don’t work, these drugs will harm them, and they are financially toxic.” NBCC President Fran Visco is right: the FDA's drug approvals system must prioritize drugs that are effective and extend lives.
stopbreastcancer.org
NBCC President Fran Visco discusses the FDA’s drug approval process and what it means for patient health and well-being.
0
1
1
Join us and take action to urge your Congressmembers to cosponsor the Metastatic Breast Cancer Access to Care Act today! https://t.co/IeHS1LSE2R
0
1
2
Historical redlining, a discriminatory housing policy outlawed in the 1960s, continues to impact neighborhood resources today and has been linked to disparities in breast cancer risk and survival. Register for our July 10th webinar to learn more!
stopbreastcancer.org
Learn about the upcoming webinars on breast cancer science and policy offered to NBCC members.
0
2
2
Research saves lives. That's why we are fighting to protect research funding and urging our elected leaders to do everything in their power to prevent damaging cuts to health care access. Join us — Take action today! https://t.co/O2LSPS8Jt6
0
1
1
"In a country that spends more on healthcare than any other country and gets the least out of it, we need to unite together to ensure everybody has the care they need." TAKE ACTION today and urge Congress to oppose any cuts to our healthcare! https://t.co/O2LSPS8Jt6
0
1
1
Apply for the Public Policy Academy, a year-long virtual training program that convenes monthly to help breast cancer advocates learn effective advocacy skills and offers year-round opportunities to shape breast cancer policies and support research funding https://t.co/GkBKi794F7
0
1
1
1/ 🧵The US Senate has voted to pass a massive budget reconciliation bill that would result in 17 million people losing healthcare coverage, while raising costs for 20 million more. The updated legislation now goes back to the US House before going to the president for signing.
1
1
2
3/ Your voice is particularly needed if you live in any of these congressional districts. Contact your reps now: https://t.co/ui4EEr9kL3
0
1
1
🎯 Too many targets. Too little time. ⏳ On June 11, 2025, Taletrectinib received FDA approval for advanced ROS1+ NSCLC. With impressive ORR and CNS activity, it reshapes the ROS1 landscape. 🧠 To keep track of all genetically driven NSCLC therapies, we created this clean,
8
64
194
@PTarantinoMD I don’t know that you can say that Destiny Breast 09 is practice changing. A lot of us are much more interested in a DEMETER approach with T’Dxd x6 followed by maintenance. Indefinite T’Dxd from the moment of diagnosis is a big pill to swallow and not patient friendly.
2
5
34
@oncology_bg They should have used he Guidance for Discussants! https://t.co/9PfG6P9J3M
ejcancer.com
Discussants of potentially practice-changing randomized clinical trials (RCTs) at major cancer meetings have an important responsibility to place new research in the context of current cancer care,...
0
1
3
Indeed. TBH, the discussant of the Serena 6 trial seemed to have hit most of the points of the checklist. Matterhorn on the other hand is a completely different story.
@oncology_bg They should have used he Guidance for Discussants! https://t.co/9PfG6P9J3M
0
2
5